Seems like CSL's Kcentra was approved in 2013, not 2023.
Resmed published a travel compliance letter for airview 2, which mentions "fda approved" in the first paragraph, around the date listed by Bard. So I'd say Bard was struggling with context there.
Seems if you want to use Bard to look for TH->Approval precedents you're better off using it as a rough guide and looking up the subject of the approval and disregard the dates given by the AI.
Ann: Trading Halt, page-182
-
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.025(7.25%) |
Mkt cap ! $597.3M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 34.5¢ | 32.0¢ | $5.335M | 15.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 331381 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 570616 | 12 |
View Market Depth
| Last trade - 15.05pm 01/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |